References
- Shah PK. New insights into the pathogenesis and prevention of acute coronary syndromes. Am J Cardiol 1997;79:17-23 https://doi.org/10.1016/S0002-9149(97)00381-0
- Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/ non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/ Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol 2007;50:e1-157馍飬Ꞁ觬莁鰠볫ꂥ밠냭閩造†鳪떭밠룪떭⃭莜賫辄⃬袘†듬隑飪늽뗬ꂕ鳭鞘ꧫ늕 뷯뾽뷯Ɥ캻뷯뾽⃧閰뷯뾽†ꓬ隑Ā 렴㶾 퀃 磬㢹 쀒 ༃ ܀난⃫炙禹 ?㶾 鶘⃬꒑†듪낕곬鲠⃬ꊅ゚禹 ?ﺝ ꣷ㢹 磬㢹 퀃 ꢃﺝ ꣷ¹ ﯪ威 ꓭ蒰臫莉駪뢰ꌇ 蓫Ā ?ﺝ 뢼ₓ 肼ₓ ꣷ㢹 磬㢹 က 威 뤠냫나⃬蚌蓭誸꣬隴頠††ਠ††Ḡ††††ठ 䄀 돐⨀ 〽 裇?⨀ က 威 룪늽⃬릴듬誤处 돀ᢰ?⨀ ⁊ 렼 磃?⨀ 돐 飃?⨀ ႐?⨀ 宐㽁⁁獦慲椬⁚⸻⁂潨浥爬⁖⸻⁈慲牯睦 뷯뾽뷯뾽뷯뾽뷯뾽봠㬠† 겲⌮촾㊹コ뤠䁇?浇 蚰䉁 宐㽁 劶䙁Ȁ ᔀ Ѐ︀ 宐㽁겲⌮촾 宐㽁㊹コ뤠䁇 Ā ?浇 Ȁ ㊹コ뤠䁇 ?浇 袛얖⨀ ₐ?⨀ 鄈 돀좰?⨀ 塨?⨀ 僉?⨀ 椈 돐 衕잖⨀ 烉?⨀ ⁈慲牯睦 뷯뾽뷯뾽뷯뾽뷯뾽봠㬠† 겲⌮촾㊹コ뤠䁇?浇 蚰䉁 宐㽁 劶䙁Ȁ ᔀ ︀ 宐㽁겲⌮촾 宐㽁㊹コ뤠䁇 Ā ?浇 Ȁ ㊹コ뤠䁇 ?浇 頷얖⨀ ₐ?⨀ Ā 돐냀?⨀ 偭⨀ 耋?⨀ ᠀ ྚᘛ᠘䡇悓?⨀ ऀ ᤀ ⚘阛᠘䡇肓?⨀ ऀ ᨀ 鎘阛᠘䡇ꂓ?⨀ ऀ ᬀ 鎘阛᠘䡇삓?⨀ ऀ ᰀ https://doi.org/10.1016/j.jacc.2006.12.050
- Logeart D, Thabut G, Jourdain P, et al. Predischarge B-type natriuretic peptide assay for identifying patients at high risk of readmission after decompensated heart failure. J Am Coll Cardiol 2004;43:635-41 https://doi.org/10.1016/j.jacc.2003.09.044
- Chung IH, Yoo BS, Ryu HY, et al. The relationship between the early follow-up BNP level and congestive status or prognosis in acute heart failure. Korean Circ J 2006;36:200-7
- de Lemos JA, Morrow DA, Bentley JH, et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 2001;345:1014-21 https://doi.org/10.1056/NEJMoa011053
- Omland T, Persson A, Ng L, et al. N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes. Circulation 2002;106:2913-8 https://doi.org/10.1161/01.CIR.0000041661.63285.AE
- Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004;8:R204-12 https://doi.org/10.1186/cc2872
- Rakowski H, Appleton C, Chan KL, et al. Canadian consensus recommendations for the measurement and reporting of diastolic dysfunction by echocardiography: from the Investigators of Consensus on Diastolic Dysfunction by Echocardiography. J Am Soc Echocardiogr 1996;9:736-60 https://doi.org/10.1016/S0894-7317(96)90076-0
- Hillis GS, Ujino K, Mulvagh SL, Hagen ME, Oh JK. Echocardiographic indices of increased left ventricular filling pressure and dilation after acute myocardial infarction. J Am Soc Echocardiogr 2006;19:450-6 https://doi.org/10.1016/j.echo.2005.11.007
- Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002;347:161-7 https://doi.org/10.1056/NEJMoa020233
- Omland T, Aakvaag A, Vik-Mo H. Plasma cardiac natriuretic peptide determination as a screening test for the detection of patients with mild left ventricular impairment. Heart 1996;76:232-7 https://doi.org/10.1136/hrt.76.3.232
- Yoo BS, Kim WJ, Jung HS, et al. The clinical experiences of Btype natriuretic peptide blood concentrations for diagnosis in congestive heart failure: the single hospital experience based on the large clinical database. Korean Circ J 2004;34:684-92
- Omland T, Aakvaag A, Bonarjee VV, et al. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction: comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide. Circulation 1996;93:1963-9 https://doi.org/10.1161/01.CIR.93.11.1963
- Morrow DA, de Lemos JA, Sabatine MS, et al. Evaluation of Btype natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18. J Am Coll Cardiol 2003;41:1264-72 https://doi.org/10.1016/S0735-1097(03)00168-2
- Galvani M, Ottani F, Oltrona L, et al. N-terminal pro-brain natriuretic peptide on admission has prognostic value across the whole spectrum of acute coronary syndromes. Circulation 2004;110:128-34 https://doi.org/10.1161/01.CIR.0000134480.06723.D8
- Omland T, de Lemos JA, Morrow DA, et al. Prognostic value of N-terminal pro-atrial and pro-brain natriuretic peptide in patients with acute coronary syndromes. Am J Cardiol 2002;89:463-5 https://doi.org/10.1016/S0002-9149(01)02271-8
- Jernberg T, Stridsberg M, Venge P, Lindahl B. N-terminal pro brain natriuretic peptide on admission for early risk stratification of patients with chest pain and no ST-segment elevation. J Am Coll Cardiol 2002;40:437-45 https://doi.org/10.1016/S0735-1097(02)01986-1
- James SK, Lindahl B, Siegbahn A, et al. N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudy. Circulation 2003;108:275-81 https://doi.org/10.1161/01.CIR.0000079170.10579.DC
- Baek KK, Jeon ES, Rhee IL, et al. N-terminal pro-B-type natriuretic peptide as a prognostic marker in acute coronary syndrome. Korean Circ J 2004;34:1070-81 https://doi.org/10.4070/kcj.2004.34.11.1070
- Kragelund C, Gronning B, Kober L, Hildebrandt P, Steffensen R. N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease. N Engl J Med 2005;352:666-75 https://doi.org/10.1056/NEJMoa042330
- Omland T, Sabatine MS, Jablonski KA, et al. Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial. J Am Coll Cardiol 2007;50:205-14 https://doi.org/10.1016/j.jacc.2007.03.038
- St John Sutton M, Pfeffer MA, Plappert T, et al. Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction: the protective effects of captopril. Circulation 1994;89:68-75 https://doi.org/10.1161/01.CIR.89.1.68
- Richards AM, Nicholls MG, Yandle TG, et al. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. Circulation 1998;97:1921-9 https://doi.org/10.1161/01.CIR.97.19.1921
- Tateishi J, Masutani M, Ohyanagi M, Iwasaki T. Transient increase in plasma brain (B-type) natriuretic peptide after percutaneous transluminal coronary angioplasty. Clin Cardiol 2000;23:776-80 https://doi.org/10.1002/clc.4960231016
- Marumoto K, Hamada M, Hiwada K. Increased secretion of atrial and brain natriuretic peptides during acute myocardial ischaemia induced by dynamic exercise in patients with angina pectoris. Clin Sci 1995;88:551-6